PRODUCTS

Product Description


Cellico AR glasses : Arges v1.0

Arges are smart glasses for people who suffer from age-related macular generation (AMD), the leading cause of vision loss. Arges glasses use a small 4k camera and mobile app to capture and process images in real-time. The images are then displayed back to the user with an augmented reality display in Full-HD. This process moves the central vision to the peripheral field of view, allowing AMD patients to recover their lost vision and regain independence.

Item specifics
Model NumberAR1.01
Display resolution
1080p
Display field of view
47º
Camera resolution
4k
Connectivity Technology
USB-C
Length
6.92 in
Width
6.14 in
Height
1.97 in
Weight
3.31 oz
P R O D U C T S
Cellico AR glasses : TheraView

TheraView is a smart glasses for people who suffer from retina diseases such as age-related macular generation (AMD) and Retinitis Phigmentosa. TheraView glasses use a small 4k camera and mobile app to capture and process images in real-time. The images are then displayed back to the user with an augmented reality display in Full-HD. This process moves the dark-spot vision to the peripheral field of view, allowing patients to recover their low or lost vision and regain independence.

Item specifics
Model NumberTV1.01
Display resolution
1080p
Display field of view
41º
Camera resolution
4k
Connectivity Technology
USB-C
Length
6.8 in
Width
6.1 in
Height
1.8 in
Weight
3 oz

Retinal Disease


The main cause of age-related macular degeneration is aging. The macular area is lost and degenerates due to various factors related to aging and resulting in loss of function. As you get older, your chances of getting it increase. As the world is constantly entering an aging society, the number of patients with macular degeneration increases every single day.

Product Description
Retinal Disease

The main cause of age-related macular degeneration is aging. The macular area is lost and degenerates due to various factors related to aging and resulting in loss of function. As you get older, your chances of getting it increase. As the world is constantly entering an aging society, the number of patients with macular degeneration increases every single day.

Cellico’s Solution

Cellico proposes a solution for the AMD patients. TheraView glasses developed by Cellico use a small 4k camera and mobile app to capture and process images in real-time. The images are then displayed back to the user with an augmented reality display in Full-HD. This process moves the central vision to the peripheral field of view, allowing retina disease patients to recover their lost vision and regain independence.

TheraView Key points

1. 4K camera with OIS on the AR glasses 

2. Mobile App with a customized image processing engine

3. Full HD Reflective Freeform crystal Lens with a FoV of 41º

4. Voice control function 

5. Electric Auto Sunshade coated with a PDLC flim 

6. Light weight due to Titanium and Ultem materials  

Cellico’s Solution


Cellico proposes a solution for the AMD patients. Arges glasses developed by Cellico use a small 4k camera and mobile app to capture and process images in real-time. The images are then displayed back to the user with an augmented reality display in Full-HD. This process moves the central vision to the peripheral field of view, allowing AMD patients to recover their lost vision and regain independence.

Arges Key points


1. 4K camera on the AR glasses 

2. Mobile App with a customized image processing engine

3. Full HD Reflective Waveguide Lens with a FoV of 47º

4. Voice control function 

5. Electric Auto Sunshade coated with a PDLC flim 

6. Light weight due to Titanium and Ultem materials  

CELLICO

주소 경기도 성남시 수정구 대왕판교로 815,

7층 R765(시흥동, 판교창조경제밸리)

E-MAIL info@cellico.com

사업자등록번호 792-87-01531


Copyright © 2020 cellico. All Rights Reserved. 

CELLICO | Address  R765, 815, Daewangpangyo-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, 13449, Republic of Korea 

E-mail info@cellico.com | Business Registration # 792-87-01531 

Copyright © 2020 cellico. All Rights Reserved.